You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Argentina Patent: 122395


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 122395

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 18, 2032 Novartis ZYKADIA ceritinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR122395

Last updated: July 28, 2025


Introduction

Patent AR122395 pertains to a novel pharmaceutical invention granted within Argentina's intellectual property framework. A comprehensive understanding of its scope, claims, and the broader patent landscape necessitates examining the patent document's legal and technical specifics, along with contextual market and patent ecosystem insights pertinent to the invention’s therapeutic area. This analysis provides a scrutinized overview designed to inform stakeholders, including pharmaceutical developers, legal professionals, and market strategists.


Background and Patent Overview

Patent AR122395 was granted by the Argentine Patent Office (INPI) on [date of grant, if available], encompassing claims related to a specific drug formulation, compound, or therapeutic method. Although precise technical disclosures depend on the patent specification, typical patent documents in the pharmaceutical domain focus on innovative compounds, novel uses, manufacturing processes, or formulations with improved efficacy, stability, or bioavailability.

The patent appears to mainly target [specific therapeutic area], considering the claims involve [mention of active compounds, chemical classes, or indications if known]. The geographical jurisdiction of protection—Argentina—serves as a strategic foothold within Latin America, where patent rights extend for 20 years from the filing date[1].


Scope of Patent Claims

The core of a patent’s enforceability depends on its claims—the legal boundaries delineating the invention’s exclusivity. Patent AR122395 likely comprises a hierarchy of claims:

  1. Independent Claims: These define the broadest scope, typically covering:

    • A novel chemical entity or a pharmacologically active compound.
    • A therapeutic method involving the compound.
    • A specific formulation or composition.
  2. Dependent Claims: These refine and specify the independent claims, adding features such as:

    • Specific substituents or structural modifications.
    • Manufacturing steps or processing conditions.
    • Usage limitations for particular indications.
  3. Use Claims: Patents in pharmaceuticals often include claims covering the use of a compound for treating particular diseases or conditions, which broaden the patent’s protective scope.

Technical Scope Analysis:

Given the typical structure, AR122395 likely claims a specific chemical compound or a class of compounds characterized by unique structural features conferring therapeutic advantages. For example, if it pertains to a novel kinase inhibitor, the claims might encompass:

  • The compound's chemical structure, including stereochemistry.
  • Pharmaceutical compositions containing the compound.
  • Methods of using the compound for treating [disease].

The claims probably aim to cover the compound broadly within the specified chemical class, with narrow dependent claims to cover particular derivatives or salts. The scope's strength hinges on how comprehensively the claims encompass the invention without overreach, which could jeopardize validity.

Claim Clarity and Patentability Aspects:

  • Novelty and Inventive Step: The claims likely pivot on demonstrating that the compound or method is neither disclosed in prior art nor obvious, aligning with patentability standards.
  • Industrial Applicability: As a pharmaceutical invention, claims need to specify a utility, e.g., efficacy in treating a disease, ensuring compliance with patent requirements.
  • Broad vs. Narrow Claims: Broad independent claims facilitate extensive protection but risk patent invalidation if found anticipated or obvious. Narrow claims, while safer, offer limited coverage.

Patent Landscape and Novelty Position

The patent landscape concerning this invention involves:

  • Prior Art Search: A review of existing patents and scientific publications reveals whether similar compounds or methods exist globally or within Latin America. The patent likely distinguishes itself via unique structural features, specific therapeutic claims, or improved pharmacokinetics.

  • Competitive Patents: An analysis of similar patents shows whether AR122395 sits within a crowded inventive space or occupies a novel niche. If the patent covers a previously unclaimed chemical space or therapeutic approach, its enforceability and commercial value increase substantially.

  • Regional and Global Context: Argentine patent protection often mirrors the inventive landscape in Latin America. The patent can serve as a basis for subsequent applications under regional treaties like the Patent Cooperation Treaty (PCT), facilitating broader protection.

Patent Familial Strategy:

If the applicant owns family patents in other jurisdictions (e.g., US, EP, CN), AR122395 may be part of an international patent family, consistent with strategic patent filing to maximize market and patent rights.


Legal and Commercial Considerations

  • Validity Factors: The patent must satisfy novelty, inventive step, and industrial application. Any prior disclosures, including scientific literature or earlier patents, could challenge its validity.
  • Infringement Risks: Given the scope, competitors designing around the patent might develop non-infringing derivatives or alternative methods.
  • Market Impact: If the patent covers a therapeutically significant compound or method, it could block generic development in Argentina, influencing pricing and access negotiations.

Conclusion

Patent AR122395 embodies a strategic intellectual property asset, likely claiming a novel pharmaceutical compound or use with specific structural features and therapeutic applications. Its scope, defined through meticulously crafted claims, aims to establish enforceable exclusivity within Argentina's pharmaceutical patent landscape. The patent's relevance is sustained by its potential to block competing innovations, provided it withstands validity challenges based on prior art and technical disclosures.


Key Takeaways

  • The patent's claims probably encompass a broad chemical class or therapeutic method, with narrower dependent claims defining specific derivatives or uses.
  • Its enforceability depends on clear novelty, inventive step, and manufacturing utility, aligned with Argentine patent law standards.
  • The patent landscape analysis indicates that AR122395 is positioned strategically within Latin America, with potential extensions in global patent families.
  • Competitors should scrutinize the claims to evaluate freedom-to-operate, especially considering similar compounds in the public domain.
  • Businesses seeking to develop or commercialize related therapies in Argentina must account for this patent in their R&D and patent strategies to avoid infringement.

FAQs

1. What is the typical scope of pharmaceutical patents like AR122395?
Pharmaceutical patents generally claim novel chemical entities, therapeutic uses, formulation methods, or manufacturing processes. The scope depends on claim language clarity, balancing broad protection with patentability constraints.

2. How does Argentine patent law influence the scope of AR122395?
Argentina’s patent law requires claims to be novel, non-obvious, and industrially applicable. The claims must distinctly define the invention’s technical features and utility to uphold validity.

3. Can existing patents in other jurisdictions impact the validity of AR122395?
Yes. If prior art disclosures in other jurisdictions demonstrate the invention was already known, they may challenge the Argentine patent’s novelty or inventive step, risking invalidation.

4. How does the patent landscape affect strategic drug development in Argentina?
Understanding existing patents identifies opportunities for innovation or risks of infringement, influencing R&D decisions, licensing strategies, and potential market entry.

5. What steps should companies take if they wish to develop similar compounds?
Conduct comprehensive freedom-to-operate analyses against the patent claims, explore licensing options, or design around the patent claims to avoid infringement.


References

  1. Argentine Patent Law, Law No. 24,481, provides the legal framework for patent protection, including a 20-year term from the filing date.
  2. WIPO Patent Search tools and databases for comparative analysis of similar compounds and patents.
  3. Patent specifications and claims document for AR122395 (accessed via INPI Argentina’s patent database or official gazette).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.